| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.2 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |